MICROALBUMIN STATUS AS AN EARLY BIOMARKER IN RELATION TO OTHERS IN KIDNEY DISEASE- A COMPARATIVE STUDY

Ms. Meena Sonawane, Dr. A. P. Thorat, Dr. Abhay Jagtap

Abstract


To study efficacy of microalbumin status as an early biomarker in kidney disorder in relation and along with other biomarkers

Methods-A comparative study was done in different 55 patients presented with symptoms of kidney disease at different stages. Four groups of 55 patients were studied.  Group-I of diabetic patients, Group-II of Chronic Kidney Disease (CKD), Group-III of Acute Kidney injury (AKD) and Group-IV of patients under dialysis conditions. A detailed history and clinical examination were done.

Result- All the selected biomarkers included in study seems to be increased from Group I to Group IV, (except calcium) and microalbumine was found to be effective early stage biomarker.

Summary: blood urea and creatinine level of patients with CKD was done as routine test and Microalbumine was suggested to consider as early stage effective biomarker which can predict at hypertensive and diabetic case.


Keywords


Kidney disease, microalbumine, Diabetics.

Full Text:

PDF

References


Molitoris Beuce S.:Acute Kidney Injury: Goldman Lee,Schafer Andrew I.,editors.Goldman’s Cecil Medicine,24 TH ed.Philadelphia:Elsevier Saunders;2012.p756-760.

Waikar SS,Bonventre JV:Acute Kidney Injury: Longo, Fauci, Kasper, Hauser, Jameson, Loscalzo, editors: Harrison’s Principles of Internal Medicine,18th ed, New York:Mc Graw-Hill; 2012.p2293-308.

Fink H.A., Ishani A., Taylor B.C., Greer N.L., MacDonald R., Rossini D., Sadiq S., Lankireddy S., Kane R.L., Wilt T.J. Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and Treatment. Agency for Healthcare Research and Quality; Rockville, MD, USA: 2012.

Good D.M., Zürbig P., Argiles A., Bauer H.W., Behrens G., Coon J.J., Dakna M., Decramer S., Delles C., Dominiczak A.F., et al. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol. Cell. Proteom. 2010;9:2424–2437. doi: 10.1074/mcp.M110.001917.

17. Kolch W., Neusüss C., Pelzing M., Mischak H. Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom. Rev. 2005;24:959–977. doi: 10.1002/mas.20051.

Wasung M.E., Chawla L.S., Madero M. Biomarkers of renal function, which and when? Clin. Chim. Acta. 2015;438:350–357. doi: 10.1016/j.cca.2014.08.039.

Mok C.C. Biomarkers for lupus nephritis: A critical appraisal. J. Biomed. Biotech. 2010;2010:638413. doi: 10.1155/2010/638413.


Refbacks

  • There are currently no refbacks.